Launch week offerEnds in00h00m00s

annual Promonthly Pro

Toshio Takagi

Japan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Japan

Articles (25)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Kensuke Bekku

Okayama University

JAPAN

View details

Yu Kijima

Tokyo Women's Medical University

JAPAN

View details

Hiroki Ishihara

Assistant professor

Tokyo Women's Medical University

JAPAN

View details

Kunio Kawanishi

Professor

Showa University

JAPAN

View details

Hideki Ishida

prof

Tokyo Women's Medical University

JAPAN

View details

Yasuo Kohjimoto

Associate professor

Wakayama Medical University

JAPAN

View details

Tomokazu Shimizu

Clinical professor

Tokyo Women's Medical University

JAPAN

View details

Shuji Isotani

Associate professor

Juntendo University Hospital

JAPAN

View details

Toshihito Hirai

Tokyo Women's Medical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Toshio Takagi

Research Interests

Make your next move.

Explore related searches

Articles (25)

Glomerular plasmalemma vesicle‐associated protein‐1 as an endothelial remodelling marker complementing C4d in chronic active antibody‐mediated rejection

Early Post-Transplant Hyperuricemia and Association with Histologic Fibrosis Progression and EMT-Related Changes in Proximal Tubular Cells

Factors Associated With Trifecta and Pentafecta Achievement in Robot‐Assisted Laparoscopic Partial Nephrectomy for Highly Complex Renal Tumors

Editorial Comment to Feasibility and Safety of Repeat Robot‐Assisted Partial Nephrectomy for Ipsilateral Local Recurrence: A Case Series

Belzutifan for Metastatic TFE3‐Rearranged Renal Cell Carcinoma With Pulmonary Metastases: A Case Report

Requiring Caution in the Interpretation of Donor‐Derived Cell‐Free DNA Levels During Cancer Treatment in a Kidney Transplant Recipient.: A Case Report

Anti‐Melanoma Differentiation‐Associated Gene 5 Antibody‐Positive Interstitial Lung Disease, Induced by Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Carcinoma

Impact of Cytoreductive Nephrectomy on Immune Checkpoint Inhibitor Therapy: Treatment Outcomes of Immune Inhibitors Combination Therapies for Metastatic Renal Cell Carcinoma With Primary Kidney Tumors

Risk Assessment of Cytomegalovirus Reactivation After Kidney Transplantation Under a Universal Preemptive Strategy in the Era of Intravenous Immunoglobulin‐Based Desensitization Therapy

Treatment Profile of First‐Line Immune Checkpoint Inhibitor Combination Therapy for Advanced Renal Cell Carcinoma in Patients With End‐Stage Renal Disease on Dialysis

Extended Follow‐Up of Robot‐Assisted Partial Nephrectomy for Renal Hilar Tumor: A Prospective Multi‐Institutional Study (ROBOHIT Trial)

Impact of Prolonged Warm Ischemia During Clamped Partial Nephrectomy: Comparison Between Japanese and American Cohorts

Editorial Comment on “Herpes zoster development in living kidney transplant recipients receiving low‐dose rituximab”

Tips for percutaneous nephrolithotomy for transplant kidney stone

Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up

Editorial Comment to Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP‐RCC study

Real-world efficacy and safety of cabozantinib following immune checkpoint inhibitor failure in Japanese patients with advanced renal cell carcinoma

Editorial Comment on Disease‐free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results‐Medicare data

Continuation of immune checkpoint inhibitors for newly developed brain metastasis during immune checkpoint inhibitor treatment for oligoprogressive metastatic renal cell carcinoma

Optimization of first‐line systemic therapy in patients with advanced clear cell renal cell carcinoma

Long‐term prolonged‐release tacrolimus outcomes in living donor kidney transplantation: The Japan Academic Consortium of Kidney Transplantation study‐II

Editorial Comment from Dr Ishihara et al. to Nomogram for predicting survival of renal cell carcinoma with tumor thrombus based on perioperative clinicopathological factors from a Chinese high‐volume center

Perioperative outcomes following robot-assisted partial nephrectomy for renal cell carcinoma according to surgeon generation

Analyses of operative time according to procedure phases during robot‐assisted laparoscopic partial nephrectomy using the iPhone application “My Intuitives”

Robot‐assisted laparoscopic versus open partial nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease

Collaborators (9)

Kensuke Bekku

Yu Kijima

Hiroki Ishihara

Kunio Kawanishi

Hideki Ishida

Yasuo Kohjimoto

Tomokazu Shimizu

Shuji Isotani

Toshihito Hirai

Make your next move.